BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Orexigen's Failure to Keep a Lid on it Prompts the FDA to Force a Second Study     3/4/2015
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG Partnership Terms     2/11/2015
Scientists Claim Scrapped Roche Drug Could be First Personalized Heart Med     1/23/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)     11/21/2014
Sanofi And Regeneron's Alirocumab Ph3 Trials Met Primary Efficacy Endpoint     11/20/2014
Merck & Co.'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint     11/19/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
ZS Pharma Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA     11/17/2014
Alnylam Pharmaceuticals Reports Positive Initial Phase 2 Data With Revusiran     11/14/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option     11/13/2014
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta     11/13/2014
Cardiome Pharma Corp. Touts Positive Data From Phase 3 BRINAVESS® Trial     11/7/2014
FDA Panel Backs Daiichi Sankyo, Inc.'s New A-Fib Drug Savaysa     10/31/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France)     9/17/2014
 Featured Stories
Despite Exercise, Sitting Still Linked To Heart Disease, Medical College of Wisconsin Study     3/6/2015
Popular Antidepressant Could Help Reverse Heart Failure, Temple University Study     3/5/2015
Poor Heart Function Could Be Major Alzheimer's Disease Risk, Vanderbilt University Study     3/4/2015
Coffee Prevents Clogged Arteries And Heart Attacks, Kangbuk Samsung Hospital Study     3/4/2015
Peanut Eaters May Live a Longer Life, Vanderbilt University Study     3/4/2015
Treadmill Performance Predicts Risk Of Death, Johns Hopkins University Study     3/3/2015
Elite Athletes's DNA May Hold The Secret To A Healthy Heart, Stanford University Study     3/2/2015
More Than 2 Hours Of TV A Day Ups High Blood Pressure Risk In Kids, Universidad de São Paulo Study     2/26/2015
Could Sauna Use Help You Live Longer? University Of Eastern Finland Study     2/25/2015
High Cholesterol In Mid-Life Risky For The Heart, Duke Clinical Research Institute Study     1/27/2015
Sitting Too Much? Even Exercise May Not Save You, University Health Network Study     1/21/2015
How Much Salt Should Older People Really Eat? Emory University Study     1/20/2015
Blueberries: Daily Cup May Reduce Blood Pressure, Florida State University Study     1/9/2015
An Avocado A Day Keeps Bad Cholesterol Away, Penn State University Study     1/9/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015
 More News
Ironwood Pharmaceuticals (IRWD) Initiates Phase I Clinical Study Of sGC Stimulator IW-1973     3/5/2015
Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial     3/2/2015
Merck & Co. (MRK) Release: New Data From IMPROVE-IT Study Of VYTORIN® (Ezetimibe/Simvastatin) And TRA 2ºp TIMI 50 Study Of ZONTIVITY® (Vorapaxar) To Be Presented At American College of Cardiology Scientific Sessions     2/25/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage     2/25/2015
Featured Lectures From Cardiology 2015: The 18th Annual Update On Pediatric And Congenital Cardiovascular Disease     2/16/2015
American Heart Association Release: Daily Beet Juice Lowers Blood Pressure for High Blood Pressure Sufferers     1/21/2015
AstraZeneca PLC (AZN)'s Brilinta Boosted by Major Clinical Trial Success     1/14/2015
Auspex Pharmaceuticals (ASPX) Announces Favorable Topline Results From Thorough QT Clinical Trial Of SD-809     1/12/2015
MaRS Innovation Announces Collaboration With Johnson & Johnson (JNJ) Innovation And Janssen To Advance Cardiac, Diabetes And Depression Technologies     1/12/2015
Biostar Pharmaceuticals, Inc. (BSPM) Announces Signing Of Joint Research And Development Agreement With Northwest University For Further Development Of Danshensu Yibingzhi (IDHP), A Class One Drug For Treatment Of Cardiovascular Diseases     1/8/2015
Biocryst Pharmaceuticals (BCRX) Receives Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema     12/24/2014
New Published Data Show Pluristem Therapeutics (PSTI)'s PLX Cells Protect Neurons     12/22/2014
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF     12/19/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting     12/8/2014
Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients     11/24/2014